As GLP-1 therapies reshape obesity care, one biotech company is betting that the root cause of Type 2 diabetes isn't only excessive weight but a specific fat-cell dysfunction. AdipoPharma LLC today ...
The hormone adrenomedullin disrupts insulin signaling in blood vessel cells, contributing to systemic insulin resistance in obesity-associated type 2 diabetes, according to a new study. Blocking ...
Adrenomedullin disrupts insulin signaling in blood vessels, leading to systemic insulin resistance in obesity-associated type 2 diabetes, according to a new study by a team at the Max Planck Institute ...
Obesity has become a global epidemic affecting diverse populations and leading to metabolic syndrome across different sexes and age groups. A significant aspect of obesity is the development of leptin ...
This story is sponsored by Health Utah. You're fat and tired. It's not insulin's fault. Insulin is just the messenger. When sugar levels are high in the bloodstream, insulin instructs body cells to ...
Obesity and type 2 diabetes are closely linked. Excess body fat can alter your body’s metabolic system, promote insulin resistance, and trigger inflammatory responses that affect how well your body ...
Scientists have discovered novel molecular mechanisms that contribute to recovery from diabetic kidney disease following ...
Morning Overview on MSN
Study links beta cell cholecystokinin to obesity-driven pancreatic cancer
Researchers have identified a specific hormone produced by pancreatic beta cells as a direct driver of obesity-linked pancreatic cancer in mouse models, shifting scientific attention away from insulin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results